Physician profile
Ali Roham
NPI 1851690531
$11,490.86
in general payments reported to CMS, 2019-2025
16 companies · $4,696 in 2025
The $4,696 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,455 · 2020: $228 · 2021: $389 · 2022: $492 · 2023: $1,612 · 2024: $2,619 · 2025: $4,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,400 · Food and Beverage: $3,876 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,399.66 |
| Food and Beverage | $3,875.90 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $4,010.55 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Abbvie INC. | $2,160.89 | 2023-2024 | Botox, Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $1,473.55 | 2019-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Musculoskeletal Transplant Foundation INC. | $1,246.06 | 2019-2025 | |
| Medical Device Business Services, INC. | $973.50 | 2023 | |
| Revance Therapeutics, INC. | $441.69 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $308.58 | 2019-2023 | |
| Allergan, INC. | $259.44 | 2019-2022 | |
| Merz North America, INC. | $221.68 | 2020-2023 | Xeomin |
| Solta Medical, A Division of Bausch Health US, LLC | $122.44 | 2021 | |
| Tela Bio, INC. | $115.11 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $70.50 | 2019 | |
| Motiva USA, LLC | $39.62 | 2025 | |
| Smith+Nephew, INC. | $18.70 | 2023 | Renasys Go V2 Home, Pico 14 |
| Venclose INC. | $14.32 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $14.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Roham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.